About embecta - EMBC
Embecta Corp. engages in the provision of medical devices used in the treatment of diabetes. Its products include pen needles, syringes, and safety devices complemented by a digital application. The company was founded in 1924 and is headquartered in Parsippany, NJ.
EMBC At a Glance
Embecta Corp.
300 Kimball Drive
Parsippany, New Jersey 07054
| Phone | 1-862-401-0000 | Revenue | 1.08B | |
| Industry | Medical Specialties | Net Income | 95.40M | |
| Sector | Health Technology | Employees | 1,850 | |
| Fiscal Year-end | 09 / 2026 | |||
| View SEC Filings |
EMBC Valuation
| P/E Current | 3.909 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 8.714 |
| Price to Sales Ratio | 0.769 |
| Price to Book Ratio | N/A |
| Price to Cash Flow Ratio | 4.34 |
| Enterprise Value to EBITDA | 5.389 |
| Enterprise Value to Sales | 1.898 |
| Total Debt to Enterprise Value | 0.706 |
EMBC Efficiency
| Revenue/Employee | 584,000.00 |
| Income Per Employee | 51,567.568 |
| Receivables Turnover | 7.256 |
| Total Asset Turnover | 0.899 |
EMBC Liquidity
| Current Ratio | 2.415 |
| Quick Ratio | 1.732 |
| Cash Ratio | 0.874 |
EMBC Profitability
| Gross Margin | 62.893 |
| Operating Margin | 30.479 |
| Pretax Margin | 12.616 |
| Net Margin | 8.83 |
| Return on Assets | 7.941 |
| Return on Equity | N/A |
| Return on Total Capital | 11.973 |
| Return on Invested Capital | 11.591 |
EMBC Capital Structure
| Total Debt to Total Equity | N/A |
| Total Debt to Total Capital | 181.652 |
| Total Debt to Total Assets | 129.544 |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | 179.167 |